Multiple System Atrophy

Biohaven Pharmaceutical Holding Company Ltd (NYSE: BHVN) has announced results from a focused analysis of verdiperstat trial in verdiperstat in multiple system atrophy (MSA).  Verdiperstat did not differ statistically from placebo on the prespecified primary efficacy measure or...

Iveric bio Inc (NASDAQ: ISEE) priced its underwritten public offering of 11.6 million shares at $8.60 per share, representing a discount of 4.6% from the last close price of $9.01 on Monday. Underwriters have an option to purchase up to an additional 1.7 million shares. The gross...

The shares of Alterity Therapeutics Ltd. (NASDAQ: ATHE) advanced in the after-hours session trading in New York on Monday and in the regular session in Sydney on Tuesday. What Happened: The surge came as Alterity Therapeutics reported positive data from an animal testing of ATH434 — its leading...